Cargando…
Antiplatelet antibodies in oxaliplatin-induced immune thrombocytopenia
Drug-induced immune thrombocytopenia may be potentially fatal; here we report the development of severe thrombocytopenia with strong oxaliplatin-dependent antiplatelet antibodies.
Autores principales: | Mittal, Kriti, McNamara, Michael J, Curtis, Brian R, McCrae, Keith R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100227/ https://www.ncbi.nlm.nih.gov/pubmed/25057402 http://dx.doi.org/10.1177/2054270414531126 |
Ejemplares similares
-
A case of oxaliplatin-induced immune-mediated thrombocytopenia
por: Suh, Seong Eun, et al.
Publicado: (2014) -
Case Report: Oxaliplatin-Induced Immune-Mediated Thrombocytopenia
por: Pan, Elizabeth, et al.
Publicado: (2018) -
Oxaliplatin-Induced Immune-Mediated Thrombocytopenia: A Case Report
por: Woo, Hyun Sun, et al.
Publicado: (2015) -
Antiplatelet antibody predicts platelet desialylation and apoptosis in immune thrombocytopenia
por: Zheng, Shiying Silvia, et al.
Publicado: (2022) -
Efficacy and Safety of Avatrombopag in Patients with Chronic Immune Thrombocytopenia: A Systematic Literature Review and Network Meta-Analysis
por: Wojciechowski, Piotr, et al.
Publicado: (2021)